Lund University is celebrating 350 years. Read more on lunduniversity.lu.se

Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.

Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.

Author:
  • Yan Borné
  • Margaretha Persson
  • Olle Melander
  • Gustav Smith
  • Gunnar Engström
Publishing year: 2014
Language: English
Pages: 377-383
Publication/Series: European Journal of Heart Failure
Volume: 16
Issue: 4
Document type: Journal article
Publisher: Elsevier

Abstract english

Soluble urokinase plasminogen activator receptor (suPAR) in plasma is a novel inflammatory marker thought to be released from the cell surface of neutrophils, T cells, and macrophages. Other inflammatory markers, mainly acute phase proteins produced in the liver, have been associated with the incidence of heart failure (HF) and atrial fibrillation (AF). We investigated the association between suPAR and incident HF and AF in a population-based cohort.

Keywords

  • Cardiac and Cardiovascular Systems

Other

Published
  • Cardio-vascular Epidemiology
  • Internal Medicine
  • Hypertension and Cardiovascular Disease
  • ISSN: 1879-0844
E-mail: gustav [dot] smith [at] med [dot] lu [dot] se

Associate professor

Cardiology

+46 46 17 26 33

D1232C

32

Research project participant

Cardiovascular Epigenetics

32

Research project participant

Heart Failure and Mechanical Support

32

Project manager

Molecular Epidemiology and Cardiology

+46 46 17 26 33

32

Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00